Partial
Mostly Aligned
Patient Risk:
Moderate
Summary
Some statements align with the provided label (NSAID-related gastric ulcer prevention; not to be taken during pregnancy to reduce NSAID-ulcer risk; boxed pregnancy risk; pregnancy-related uterine/birth defect/abortion risk). Several claims regarding pregnancy uses (labor induction, abortion, postpartum hemorrhage, medical abortion) are not supported by the provided label text and some contradict the label’s pregnancy contraindication wording.
Category Scores
Accurate Statements
Misoprostol is used to prevent stomach ulcers in patients taking nonsteroidal anti-inflammatory drugs (NSAIDs).
INDICATIONS AND USAGE: indicated for reducing risk of NSAID-induced gastric ulcers in high-risk patients.
Misoprostol can be used to induce labor in pregnant women.
SUPPORTED AS A WARNING CONTEXT ONLY (not an indicated use): WARNINGS states Cytotec administration to women who are pregnant can cause birth defects, abortion, premature birth or uterine rupture; uterine rupture reported when administered to induce labor.
Misoprostol can be used for medical abortion.
SUPPORTED AS A WARNING CONTEXT ONLY (not an indicated use): WARNINGS states uterine rupture has been reported when Cytotec was administered in pregnant women to induce abortion.
Misoprostol is a prostaglandin analog that mimics the effects of naturally occurring prostaglandins in the body.
Not supported by the provided label excerpts.
In the stomach, misoprostol reduces the amount of acid produced.
Not supported by the provided label excerpts.
Reducing stomach acid helps protect the stomach lining from damage caused by NSAIDs.
Not supported by the provided label excerpts.
During pregnancy, misoprostol softens the cervix.
Not supported by the provided label excerpts.
During pregnancy, misoprostol stimulates uterine contractions.
Not supported by the provided label excerpts.
Misoprostol can aid labor induction.
SUPPORTED AS A WARNING CONTEXT ONLY (not an indicated use): WARNINGS discusses administration to induce labor.
Misoprostol can aid abortion.
SUPPORTED AS A WARNING CONTEXT ONLY (not an indicated use): WARNINGS discusses administration to induce abortion.
Misoprostol is contraindicated in pregnant women who should not be or are already pregnant.
CONTRAINDICATIONS: Cytotec should not be taken by pregnant women to reduce the risk of ulcers induced by NSAIDs.
Misoprostol is contraindicated in pregnant women except when used for medical abortion or labor induction under medical supervision.
Not supported by the provided label excerpts; the provided contraindication language states Cytotec should not be taken by pregnant women to reduce the risk of ulcers induced by NSAIDs.
Unsupported Statements
Misoprostol is used to induce labor in pregnant women.
The provided label excerpts include uterine rupture reported when administered to induce labor, but do not state that misoprostol is indicated for labor induction.
Misoprostol can be used to manage postpartum hemorrhage.
No postpartum hemorrhage indication or related statement is present in the provided label excerpts.
Misoprostol can be used for medical abortion.
The provided label excerpts mention uterine rupture reported when administered to induce abortion, but do not state an indication for medical abortion.
Misoprostol is a prostaglandin analog that mimics the effects of naturally occurring prostaglandins in the body.
No mechanism/analogy statement is present in the provided label excerpts.
In the stomach, misoprostol reduces the amount of acid produced.
No gastric acid reduction mechanism is present in the provided label excerpts.
Reducing stomach acid helps protect the stomach lining from damage caused by NSAIDs.
No stomach-lining/acid-protection mechanism is present in the provided label excerpts.
During pregnancy, misoprostol softens the cervix.
No cervical softening statement is present in the provided label excerpts.
During pregnancy, misoprostol stimulates uterine contractions.
No uterine contraction mechanism statement is present in the provided label excerpts.
Misoprostol can aid labor induction.
The label excerpt only describes risk associated with administration to induce labor (warning context), not an approved use for labor induction.
Misoprostol can aid abortion.
The label excerpt only describes risk associated with administration to induce abortion (warning context), not an approved use for abortion.
Misoprostol can cause side effects including diarrhea, abdominal pain, nausea, and vomiting.
The adverse reactions section is only a heading in the provided text; no specific adverse event list is included.
Misoprostol is contraindicated in pregnant women except when used for medical abortion or labor induction under medical supervision.
The provided contraindications section does not provide such an exception; it specifically states Cytotec should not be taken by pregnant women to reduce NSAID-induced ulcer risk.
Contradictions
Low
AI Statement
Misoprostol is contraindicated in pregnant women except when used for medical abortion or labor induction under medical supervision.
Label Reference
CONTRAINDICATIONS: "Cytotec should not be taken by pregnant women to reduce the risk of ulcers induced by nonsteroidal anti-inflammatory drugs (NSAIDs)."
Important Omissions
Label-consistent counseling/conditions for women of childbearing potential (negative serum pregnancy test within 2 weeks, effective contraception, oral and written warnings, start on 2nd or 3rd day of next normal menstrual period) are not mentioned in the claims provided.
Importance:
Moderate
Dose and administration details for NSAID-induced gastric ulcer risk reduction (200 mcg four times daily with food; 100 mcg if not tolerated; take with meals and last dose at bedtime; for duration of NSAID therapy) are not included in the claims provided.
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Moderate
Several claims suggest pregnancy uses (labor induction/abortion) as therapeutic uses rather than only warning contexts, and specific adverse events are asserted without support from the provided adverse reactions excerpt. However, the label’s pregnancy risk warnings are partially reflected.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
Yes |
| Promotes Unapproved Use |
Yes |
| Hallucination Risk |
Low |
Recommendation
Mostly Aligned
Primary Issue
Multiple pregnancy and obstetric therapeutic use claims are not supported by the provided label excerpts and should be removed or reframed as warning context only. Mechanism and adverse-event lists are also unsupported.
Suggested Improvement
Limit statements to the provided label-supported indication (reducing risk of NSAID-induced gastric ulcers in high-risk patients), contraindication language (do not take in pregnant women to reduce NSAID ulcer risk), and boxed pregnancy warning context. Remove unsupported claims about labor induction/abortion indications, postpartum hemorrhage, mechanism/acid reduction, cervix softening/uterine contractions, and specific adverse events unless the full label text provides them.